Eisai: Final Study Results Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Treatment in Advanced Endometrial Cancer Presented at ESMO 2019 Congress
- Written by ACN Newswire - Press Releases
Read more //?#
.
Beyond borders: Building a scalable strategy for international hiring
For many Australian businesses, growth increasingly depends on thinking beyond local borders. As wage pressures rise, and specialised talent pool...
The Next Generation of Maritime Sustainable Solutions
As organizations globally seek innovative ways to improve sustainability and their impact on Earth, the American Waterways Operators (AWO), a lead...
Demand for Home Batteries surges as Federal Rebate Kicks In
A leading provider of energy solutions VoltX Energy has seen a 400% increase in demand for home batteries in the past three weeks as people put d...
Why Sport Remains the Safest Bet in an Uncertain World
When Rome was in crisis, its leaders did not retreat to the Senate. They went to the circus. To the chariot races. To the gladiators. Sport was no...
THE FINE LINE WITHIN HILARIOUS SIGNAGE DESIGN FAILS
It seems like design failures still occur in today’s modern branding era, despite rigorous rounds of approvals behind the scenes. One signage show...
Deputy Announces Exclusive Global Partnership with Predelo to Bring AI to Shift-Based Businesses
Deputy, the global people platform for shift-based businesses, has announced an exclusive partnership with Predelo, an AI Decision Agent-as-a-Serv...
